期刊文献+

结肠癌中p63蛋白表达及临床病理意义 被引量:1

Expression of p63 in Colonic Carcinoma and Precancerous Tissue
下载PDF
导出
摘要 研究结肠癌中p63蛋白表达及与临床病理生物学行为的关系,揭示其在结肠癌中的临床病理学意义.癌旁组织中和结肠癌组织p63阳性率分别为42%和74%,两组间比较存在显著差异(P<0.01).p63阳性率在结肠癌组织浸润达粘膜层、肌层中为62%,在结肠癌组织浸润达浆膜层中为91%,两组间比较存在差异(P<0.05);p63阳性率在发生淋巴结转移的结肠癌组织中为86%,在无淋巴结转移的结肠癌组织中为59%,两组间比较存在差异(P<0.05);p63阳性率在A﹢B期结肠癌组织中为57%,在C﹢D期结肠癌组织中为89%,两组间比较存在差异(P<0.01);p63阳性率在高分化结肠癌组织中为55%,在中低分化结肠癌组织中为87%,两组间比较存在差异(P<0.05).p63表达上调参与结肠癌发生,并与结肠癌侵袭、淋巴结转移和临床演进关系密切. To investigate the p63 expression in colonic carcinomas and its relationship with pathobiological behaviors of carcinomas and clarify the Clinicopathological significance of p63 expression in colonic carcinomas, It was found that the positive rate of p63 expression in colonic carcinoma and adjacent tissue are 74% and 42% respectively with significant difference of both groups(P 〈 0.01 ). The positive rate of p63 expression is 62% in invasive depth extending from mucosa to muscle and 91% in invasive depth extending to serosa with significant difference of both groups (P 〈 0.05 ). The positive rate of p63 expression is 86% in colonic cancers with lymph node metastasis and 59% for colonic cancerous tissue without lymph node metastasis with significant difference of both groups (P 〈 0.05 ). The positive rate of p63 expression is 57% in colonic cancerous tissue of A+B stage and 89% for colonic cancerous tissue of C+D stage with significant difference of both groups (P 〈 0.01 ). The positive rate of p63 expression in well differentiated colonic cancerous tissue is 55% and 87% in moderately- and poorly-differentiated colonic cancerous tissue with significant difference of both groups (P 〈 0.05). Up-regulated p63 expression was involved in the colonic carcinogenesis and closely linked to the invasion, lymph node metastasis and clinical progression of colonic carcinomas.
出处 《生命科学研究》 CAS CSCD 2008年第2期184-188,共5页 Life Science Research
基金 辽宁省教育厅青年基金资助(05L530)
关键词 P63蛋白 结肠癌 演进 p63 protein colonic carcinoma progression
  • 相关文献

参考文献23

  • 1CALVERT P M, FRUCHT H. The genetics of colorectal cancer[J]. Ann Intern Med, 2002, 137(7): 603-612. 被引量:1
  • 2KLAES R, FRIEDRICH T, SPITKOVSKY D, et al. Over expression of p16 (INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri[J]. Int J Cancer, 2001, 92(2): 276-284. 被引量:1
  • 3ROWLAND B D, DENISSOV S G, DOUMA S, et al. E2F transcriptional repressor complexes are critical downstream targets of P19 (ARF)/p53-induced proliferative arrest [J]. Cancer Cell, 2002, 2(1): 55-65. 被引量:1
  • 4SCHMALE H, BAMBERGER C. A novel protein with strong homology to the tumor suppressor p53[J]. Oncogene, 1997, 15: 1363-1367. 被引量:1
  • 5SHIMADA A, KATO S, ENJO K, et al. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences[J]. Cancer Res, 1999, 59 : 2781-2786. 被引量:1
  • 6KATOH I, AISAKI K I, KURATA S I, et al. p51A (TA p63 gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation[J]. Oncogene, 2000, 19: 3126- 3130. 被引量:1
  • 7YANG A, KAGHAD M, WANG Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death inducing, and dominant-negative activities[J]. Mol Cell, 1998, 2: 305-306. 被引量:1
  • 8YANG A, KAGHAD M, CAPUT D, et al. On the shoulders of giants: p63, p73 and the rise of p53 [J]. Trends Genet, 2002, 18: 90-95. 被引量:1
  • 9KAELIN W G. The emerging p53 gene family[J]. J Natl Cancer Inst, 1999, 91: 594-598. 被引量:1
  • 10KAELIN W G. The p53 gene family[J]. Oncogene, 1999, 18: 7701-7705. 被引量:1

同被引文献11

  • 1ZHOU H, van BOKHOVEN H. Regulation of vitamin meta- bolism byp53 andp63 in development and cancer[J]. Cell Cycle, 2010, 9(14): 2709. 被引量:1
  • 2VILGELM "A E, WASHINGTON M K, WEI J, et ol. Interac- tions of the p53 protein family in cellular stress response in gastrointestinal tumors[J]. Molecular Cancer Therapeutics, 2010, 9(3): 693-705. 被引量:1
  • 3LI Y, ZHOU Z, CHEN C. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin- mediated proteasomal degradation and regulates apoptosis [J]. Cell Death and Differentiation, 2008, 15(12): 1941-1951. 被引量:1
  • 4PANTANOWITZ L. Colonic adenoma with squamous metapla- sia[J]. International Journal of Surgical Pathology, 2009, 17(4): 340-342. 被引量:1
  • 5HENYNE K, SCHMITY K, MUELLER D, et al. Resistance of mitochondrial p53 to dominant inhibition[J]. Molecular Cancer, 2008, 7: 54-71. 被引量:1
  • 6UEO T, KASHIMA K, DAA T, et ol. Immunohistochemical analysis of morules in colonic neoplasms: morules are morpho- logically and qualitatively different from squamous metaplasia[J]. Pathobiology, 2005, 72(5): 269-278. 被引量:1
  • 7NAHOR I, ABRAMOVITCH S, ENGELAND K, et al. The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells[J]. Growth Hormone & IGF Research, 2005, 15(6): 388-396. 被引量:1
  • 8DIETA S, ROTHER K, BAMBERGER C, et al. Differential regulation of transcription and induction of programmed cell death by human p53-family members p63 and p73[J]. FEBS Let- ters, 2002, 525(1-3): 93-99. 被引量:1
  • 9MATSUBARA R, KAWANO S, KIYOSUE T, et al. Increased △Np63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma[J]. International Journal of Oncology, 2011, 39(6): 1391-1399. 被引量:1
  • 10CANDI E, DINSDALE D, RUFINI A, et d. TAp63 and delta Np63 in cancer and epidermal development[J]. Cell Cycle, 2007, 6(3): 274-285. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部